<DOC>
	<DOCNO>NCT02059330</DOCNO>
	<brief_summary>This study investigate dose-proportionality palbociclib pharmacokinetics healthy subject Japanese descent . Approximately fourteen healthy Japanese subject receive four single dos palbociclib ( PD-0332991 ) minimum washout 10 day dos . Additionally , study investigate effect Japanese ethnicity palbociclib pharmacokinetics compare palbociclib pharmacokinetics single dose-level healthy subject Japanese descent approximately fourteen healthy non-Asian subject .</brief_summary>
	<brief_title>A Study To Investigate Palbociclib ( PD-0332991 ) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects , And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Palbociclib</mesh_term>
	<criteria>Subjects must healthy male female nonchildbearing potential Subjects must BMI ( Body Mass Index ) 17.5 30.5 kg/m2 To eligible Japanese cohort , subject must 4 biological grandparent Japanese born Japan Any condition affect drug absorption ( eg gastrectomy , achlorhydria , etc ) Use prescription nonprescription drug A QTcinterval &gt; 450msec QRS interval &gt; 120msec Pregnant breastfeeding female , female childbearing potential , male unwilling unable use effective method contraception duration study 90 day last dose palbociclib study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Japanese PK-Bridging Study</keyword>
	<keyword>dose-proportionality study</keyword>
	<keyword>Palbociclib</keyword>
	<keyword>PD-0332991</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>